Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?

dc.contributor.authorWish, Jay B.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2021-08-09T13:20:22Z
dc.date.available2021-08-09T13:20:22Z
dc.date.issued2020-08-25
dc.identifier.citationWish, J. B. (2020). Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged? Kidney Medicine, 2(5), 526–528. https://doi.org/10.1016/j.xkme.2020.08.002en_US
dc.identifier.issn2590-0595en_US
dc.identifier.urihttps://hdl.handle.net/1805/26372
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.xkme.2020.08.002en_US
dc.relation.journalKidney Medicineen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePMCen_US
dc.subjecterythropoiesis-stimulating agenten_US
dc.subjecthemoglobinen_US
dc.subjectCorrection of Hemoglobin in the Outcomes in Renal Insufficiency studyen_US
dc.titleErythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
main (19).pdf
Size:
304.71 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: